Mosquito-killing drug offers new tool for fighting malaria
Red Book
Red Book

Interview Guidance Program (IGP) for UPSC CSE 2024, Registrations Open Click Here to know more and registration
  1. In a randomized trial in Burkina Faso, the antimalarial effects of ivermectin has shown that it has the potential to reduce malaria episodes. Burkina Faso is a country in western Africa.
  2. Ivermectin reduces new cases of malaria by making a person’s blood lethal to the mosquitoes who bite them, killing mosquitoes. It therefore reduces the likelihood of infection of others.
  3. Ivermectin is a drug used to treat parasitic infections such as head lice, river blindness and scabies. Mosquito-killing capabilities of the drug has been known, however, it had not previously been tested for its effects on malaria incidence.
  4. Malaria is disease caused by Plasmodium parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. According to the World Malaria Report 2018, more than 200 million people were affected by malaria in 2017. Africa has the highest malaria burden.

Discover more from Free UPSC IAS Preparation Syllabus and Materials For Aspirants

Subscribe to get the latest posts sent to your email.

Print Friendly and PDF
Blog
Academy
Community